Korrespondenz-Adresse

Prof. Dr. U. Wollina
Former head of Department of Dermatology and Allergology
Städtisches Klinikum Dresden-Friedrichstadt
Friedrichstr. 41
DE-01067 Dresden
Email: uwollina@gmail.com

Conflict of Interests

Es besteht kein Onteressenkonflikt.

Literatur

1. Owczarczyk-Saczonek A, Zdanowska N, Wańczyk-Dręczewska B, Wygonowska E, Placek W, Griffiths CC, et al. Pyoderma gangrenosum-like lesions provocated by botulinum injections. Dermatol Ther 2020:e13227.
2. Park JY, Byun EJ, Kim HS. Rejuvenation of periocular region in Koreans: A multimodal approach combining botulinum toxin, fillers, and micro-focused ultrasound with visualization for optimal results. Dermatol Ther 2019:e13159.
3. Aksu Arica D. Cosmetical treatments of connective tissue disorders. Dermatol Ther. 2019;32(4):e12935.
4. França K, Castillo D, Lotti T. Non-cosmetic dermatological use of botulinum neurotoxin. Dermatol Ther. 2017; 30(4): doi: 10.1111/dth.12495.
5. Wollina U, Goldman A, Berger U, Abdel-Naser MB. Esthetic and cosmetic dermatology. Dermatol Ther 2008;21(2):118-30.
6. Zhu J, Ji X, Xu Y, Liu J, Miao YY, Zhang JA, Luo D, Zhou BR. The efficacy of intradermal injection of type A botulinum toxin for facial rejuvenation. Dermatol Ther. 2017;30(1). doi: 10.1111/dth.12433.
7. Hexsel C, Hexsel D, Porto MD, Schilling J, Siega C. Botulinum toxin type A for aging face and aesthetic uses. Dermatol Ther 2011; 24(1):54-61.
8. The American Society for Aesthetic Plastic Surgery's Cosmetic Surgery National Data Bank: Statistics 2018. Aesthet Surg J. 2019;39(Suppl_4):1-27.
9. Coleman KR, Carruthers J. Combination therapy with BOTOX and fillers: the new rejuvenation paradigm. Dermatol Ther 2006; 19(3):177-88.
10. Wollina U. Botulinum toxin type A: Anabotulinum A, onabotulinum A, and incabotulinum A – differences and common sense. Kosmet Med. 2015;36(3):112-14.
11. Patil A, Kassir M, Wollina U, Goldust M. Neue Botulinumtoxine in der ästhetischen Dermatologie: Ein umfassender Überblick. Hautarzt. 2021;72(5):393-402.
12. Picelli A, Tamburin S, Di Censo R, Smania N, Filippetti M. Does the diffusion profile differ between botulinum toxin type A formulations? Implications for the management of post-stroke spasticity. Toxins (Basel). 2024;16(11):480.
13. de Almeida AT, de Sanctis Pecora C, Marques ER, Contin L, de Almeida CT, da Cunha AL. Assessment of the efficacy and durability of incobotulinumtoxina in the treatment of the upper face in adult women. Dermatol Ther (Heidelb). 2024;14(8):2093-108.
14. Bertucci V, Green JB, Fezza JP, Brown J, Gallagher CJ, Solish N. Impact of glabellar injection technique with daxibotulinumtoxin A for injection on brow position. Aesthet Surg J. 2023;43(Suppl 1):S10-8.
15. Kamat A, Quadros T. An observational study on glabellar wrinkle patterns in Indians. Indian J Dermatol Venereol Leprol. 2019;85(2):182-89.
16. Kassir M, Gupta M, Galadari H, Kroumpouzos G, Katsambas A, Lotti T, Vojvodic A, Grabbe S, Juchems E, Goldust M. Complications of botulinum toxin and fillers: A narrative review. J Cosmet Dermatol. 2020;19(3):570-573.
17. Wollina U, Konrad H. Managing adverse events associated with botulinum toxin type A: a focus on cosmetic procedures. Am J Clin Dermatol. 2005;6(3):141-50.
18. Borba A, Matayoshi S, Rodrigues M. Avoiding complications on the upper face treatment with botulinum toxin: a practical guide. Aesthetic Plast Surg. 2022;46(1):385-94.
19. Nestor MS, Han H, Gade A, Fischer D, Saban Y, Polselli R. Botulinum toxin-induced blepharoptosis: Anatomy, etiology, prevention, and therapeutic options. J Cosmet Dermatol. 2021;20(10):3133-46.
20. Carruthers A, Carruthers J, De Boulle K, Lowe N, Lee E, Brin MF. Treatment of crow's feet lines and forehead lines with Botox (onabotulinumtoxin A): Development, insights, and impact. Medicine (Baltimore). 2023;102(S1):e32496.
21. Yao A, Malhotra R. Do botulinum toxin injections for upper face rejuvenation and lateral canthal rhytids have unintended effects on tear production? Ophthalmic Plast Reconstr Surg. 2024; doi: 10.1097/IOP.0000000000002785. Epub ahead of print.
22. Skorochod R, Nesher R, Nesher G, Gronovich Y. Ophthalmic adverse events following facial injections of botulinum toxin A: A systemic literature review. J Cosmet Dermatol. 2021;20(8):2409-13.
23. Klein AW. Contraindications and complications with the use of botulinum toxin. Clin Dermatol. 2004;22(1):66-75.
24. Carruthers A, Carruthers J. Botulinum toxin type A: history and current cosmetic use in the upper face. Semin Cutan Med Surg. 2001;20(2):71–84.
25. Braccini F, Catoni I, Belfkira F, Lagier J, Roze E, Paris J, Huth J, Bronsard V, Cartier H, David M, Galatoire O, Obadia D, Sabatier H, Sarfati E, Kestemont P, Winter C, Redaelli A. SAMCEP Society consensus on the treatment of upper facial lines with botulinum neurotoxin type A: A tailored approach. J Cosmet Dermatol. 2023;22(10):2692-704.
26. Fisher E. Applications for neurotoxins in the face and neck. Atlas Oral Maxillofac Surg Clin North Am. 2024;32(1):7-14.
27. de Maio M, Wu WTL, Goodman GJ, Monheit G; Alliance for the Future of Aesthetics Consensus Committee. Facial assessment and injection guide for botulinum toxin and injectable hyaluronic acid fillers: focus on the lower face. Plast Reconstr Surg. 2017;140(3):393e-404e.
28. Auada Souto MP, Souto LRM. An unusual adverse event of botulinum toxin injection in the lower face. J Cosmet Dermatol. 2021;20(5):1381-4.
29. Yeh YT, Peng JH, Peng HL. Literature review of the adverse events associated with botulinum toxin injection for the masseter muscle hypertrophy. J Cosmet Dermatol. 2018;17(5):675-87.
30. Evin N, Sifil MK, Aghazada TM, Özcan ED, Guneren E. Velopharyngeal insufficiency after botox injection for persistent bruxism. J Craniofac Surg. 2024;35(2):495-497.
31. Zargaran D, Zoller FE, Zargaran A, Mosahebi A. Complications of facial cosmetic botulinum toxin A injection: analysis of the UK Medicines & Healthcare Products Regulatory Agency registry and literature review. J Plast Reconstr Aesthet Surg. 2022;75(1):392-401.
32. Wollina U, Goldman A. Facial vascular danger zones for filler injections. Dermatol Ther. 2020;33(6):e14285.
33. Maytharakcheep S, Phokaewvarangkul O, Bhidayasiri R. Does needle size matter? Effects of micro-hypodermic needle injections of botulinum toxin type A in patients with hemifacial spasm. Parkinsonism Relat Disord. 2024;118:105950.
34. Kim SB, Hu H, Lee HJ, Yi KH. Sonoanatomy of injecting botulinum neurotoxin into the facial muscles. Surg Radiol Anat. 2024;46(8):1237-1252.
35. Thanasarnaksorn W, Rattakul B, Suvanasuthi S, Sutthipisal N. Botulinum toxin type A injection-related suppurative granuloma: a case report. J Cosmet Laser Ther 2019; 21(7-8):422-4.
36. Popescu MN, Beiu C, Iliescu CA, Racoviță A, Berteanu M, Iliescu MG, Stănescu AMA, Radaschin DS, Popa LG. Ultrasound-guided botulinum toxin-A injections into the masseter muscle for both medical and aesthetic purposes. Toxins (Basel). 2024;16(10):413.
37. Haque EK, Darwish YR, Reddick CS. Transient localized cutaneous reaction after onabotulinumtoxinA aesthetic injection. Proc (Bayl Univ Med Cent). 2020;33(4):598-600.
38. Aryanian Z, Ehsani A, Razavi Z, Hamzelou S, Mohseni Afshar Z, Hatami P. The COVID-19 pandemic and its impact on esthetic dermatology. J Cosmet Dermatol. 2022;21(12):6557-61.
39. Liu X, Tian Y, Jiang C, Dong M, Li M, Sun H, Han X, Li F. The impact of SARS-Cov-2 infection on the periocular injection pain and hypersensitive reaction to botulinum toxin type A: results from clinical questionnaires. Front Cell Infect Microbiol. 2023;13:1240303.
40. Ou Y, Liu D, Feng J, Xu X, Lin T, Zhang Y, Luo L, Wu M, Cui Y. Subcutaneous infection caused by Mycobacterium abscessus following botulinum toxin injections: A case report and literature review. J Cosmet Dermatol. 2024 May;23(5):1527-32.
41. Fang RY, Sun QN. Mycobacterium abscessus infections following injection of botulinum toxin. J Cosmet Dermatol. 2020;19(4):817-9.
42. Careta MF, Delgado L, Patriota R. Report of Allergic Reaction After Application of Botulinum Toxin. Aesthet Surg J. 2015;35(5):NP102-5.
43. Pontes HA, Pontes FS, de Oliveira GF, de Almeida HA, Guimarães DM, Cavallero FC. Uncommon foreign body reaction caused by botulinum toxin. J Craniofac Surg. 2012;23(4):e303-5.
44. Coté TR, Mohan AK, Polder JA, Walton MK, Braun MM. Botulinum toxin type A injections: adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases. J Am Acad Dermatol. 2005;53(3):407-15.

Ausgabe

KOSMETISCHE MEDIZIN 2.25